EP3352857
SYD985 meðferð krabbameinssjúklinga sem eru ónæmir fyrir T-DM1
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.9.2016EP published:
13.1.2021EP application number:
16775553.7
EP translation filed:
11.2.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
20.9.2036Expiry date:
20.9.2024
Title:
SYD985 TREATMENT OF T-DM1 REFRACTORY CANCER PATIENTS
Timeline
Today
21.9.2016EP application
13.1.2021EP Publication
11.2.2021Translation submitted
15.3.2021Registration published
20.9.2024Expires
Owner
Name:
Byondis B.V.Address:
Microweg 22, 6545 CM Nijmegen, NL
Inventor
Name:
VOORTMAN, GerritAddress:
6545CM Nijmegen, NL
Name:
KOPER, Norbert PeterAddress:
6545CM Nijmegen, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
15186258Date:
22.9.2015Country:
EP
Number:
16158710Date:
4.3.2016Country:
EP
Number:
16169699Date:
13.5.2016Country:
EP
Classification
Categories:
A61K 47/68, A61P 35/00, A61P 35/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 31.8.2021
Expires: 20.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 31.8.2022
Expires: 20.9.2023
Payer: Patice ehf.
Number: 8
Paid: 19.9.2023
Expires: 20.9.2024
Payer: Árnason Faktor ehf.